Item 7.01 Regulation FD Disclosure.
On June 30, 2009, David M. Mulder, Chief Executive Officer of Biolase Technology, Inc., will deliver a presentation to investors that will include a written communication comprised of slides. The slides from the presentation are attached hereto as Exhibit 99.1, and are hereby incorporated by reference. A copy of the slides will be available for viewing and download at http://www.biolase.com/investors for a period of 30 days. Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Presentation material for investors, dated November 30, 2009.

---